In 2011, it was estimated that more than half a million women died due to breast cancer according to the World Health Organization. And nearly a quarter of a million (240,000) additional new cases were expected for the year of 2016. Although generally considered as a disease of the developed countries, nearly half the cases of breast cancer worldwide were in less developed countries and over 58 percent of worldwide deaths occurred in less developed countries.
A well-known method to combat cancer is chemotherapy, whereby it radiates all cells in a certain area and does not specify cancerous cells.
That’s why a new study in Amsterdam is so impressive since it’s shown results that it can destroy tumors in as little as 11 days without the use of chemo!
Cancer cells are notorious for growing and dividing rapidly, thus the use of chemotherapy has long been thought to be most effective since it reduces the speed in which it grows.
But there can be numerous side effects affiliated with chemotherapy since it can reduce the growth of other quick-growing cells such as those in the mouth and stomach (intestines,) and cells that make your hair grow.
At the European Breast Cancer Conference in Amsterdam, professor Nigel Bundred revealed research that illustrated a game-changing effectiveness in targeting cancer cells.
The researchers found some stunning evidence when they used the two drugs simultaneously before surgery and chemotherapy.
He combined the two drugs, Herceptin (also known as Trastuzumab) and Lapatinib. Although the pair is commonly used in cancer treatment already, they have never been used in a duo.
Their research showcased that they were able to eliminate some types of breast cancer completely in just 11 days. And in other cases, they found that the combination of the drugs illustrated a drastic reduction in cancer sizes.
The combination of the drugs is aimed at fighting a protein known as the human epidermal growth factor receptor 2 or HER2.
The HER2 gene creates the HER2 protein which is a receptor that dictates the growth and division of breast cancer cells.
If you Like this article ‘SHARE’ it with your friends on Facebook!